| Financial Year |
March 31 2023 |
| Monetary Funds |
116,904,907.79 |
| Held-for-trading Financial Assets |
79,855,532.30 |
| Notes Receivable |
-- |
| Accounts Receivable |
272,796,358.34 |
| Advances to Suppliers |
8,922,811.77 |
| Other Receivables |
4,108,206.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
240,918,816.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
34,848,771.96 |
| Total Current Assets |
758,355,405.37 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
241,058,591.39 |
| Under-construction Projects |
126,457,523.66 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
22,017,472.87 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,086,966.99 |
| Deferred Income Tax Assets |
18,501,316.82 |
| Other Non-Current Assets |
7,046,998.61 |
| Sub-Total of Non-Current Assets |
439,676,751.30 |
| Total Assets |
1,198,032,156.67 |
| Short-Term Loans |
150,594,884.33 |
| Trading Financial liabilities |
1,910,717.26 |
| Notes Payable |
395,903.73 |
| Accounts Payable |
254,779,588.68 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,883,082.83 |
| Taxes Payable |
1,555,636.70 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
4,781,273.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,643,901.03 |
| Other Current Liabilities |
46,696.03 |
| Sub-Total of Current Liabilities |
425,715,884.27 |
| Long-term Loans |
1,588,646.47 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
267,894.43 |
| Deferred Income Tax Liabilities |
920,129.90 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
19,460,836.68 |
| Total Liabilities |
445,176,720.95 |
| Paid-In Capital(Or Share Stock) |
96,000,000.00 |
| Capital Surplus |
423,638,632.40 |
| Surplus Reserve |
42,284,912.54 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
197,516,383.51 |
| Minority Stockholder's Interest |
2,275.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
752,853,160.10 |
| Owner's Equity（Stockholder's Equity） |
752,855,435.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,198,032,156.67 |
